The role of the tissue omega-6/omega-3 fatty acid ratio in regulating tumor angiogenesis

Cancer and Metastasis Reviews

Volumn 32, Issue 1-2, 2013, Pages 201-210

  Kang, Jing X ^a,b   Liu, Angela ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Angiogenesis; Cancer; Fatty acid ratio; Inflammation; Omega 3 fatty acids; Omega 6 fatty acids

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2; GROWTH FACTOR; ICOSANOID; INDOMETACIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ANGIOGENESIS; BREAST TUMOR; FAT INTAKE; FATTY ACID METABOLISM; HUMAN; INFLAMMATION; METABOLITE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; TUMOR GROWTH;

ANIMALS; DISEASE MODELS, ANIMAL; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84878114114     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-012-9401-9     Document Type: Review

References (101)

1. Arnold, F., & West, D. (1991). Angiogenesis in wound healing. Pharmacology & Theraputics, 52, 407-422.
2. Kleim, J. A., Cooper, N. R., & VandenBerg, P. M. (2002). Exercise induces angiogenesis but does not alter movement representations within rat motor cortex. Brain Research, 934(1), 1-6.
3. Carmeliet, P. (2003). Angiogenesis in health and disease. Nature Medicine, 9(6), 653-660.
4. Conway, E. M., Collen, D., & Carmeliet, P. (2001). Molecular mechanisms of blood vessel growth. Cardiovascular Research, 49(3), 507-521.
5. Folkman, J., Cole, P., & Zimmerman, S. (1966). Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment. Annals of Surgery, 164(3), 491-502.
6. Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100(1), 57-70.
7. Folkman, J., & Kalluri, R. (2004). Cancer without disease. Nature, 427(6977), 787.
8. Blood, C. H., & Zetter, B. R. (1990). Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochimica et Biophysica Acta, 1032(1), 89-118.
9. Naumov, G. N., Akslen, L. A., & Folkman, J. (2006). Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle, 5(16), 1779-1787.
10. Morisada, T., Kubota, Y., Urano, T., Suda, T., & Oike, Y. (2006). Angiopoietins and angiopoietin-like proteins in angiogenesis. Endothelium, 13(2), 71-79.
11. Rajkumar, T. (2001). Growth factors and growth factor receptors in cancer. Current Science, 81, 535-541.
12. Wu, Y., & Zhou, B. P. (2010). TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. British Journal of Cancer, 102(4), 639-644.
13. Li, A., Dubey, S., Varney, M. L., Dave, B. J., & Singh, R. K. (2003). IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. Journal of Immunology, 170(6), 3369-3376.
14. Kang, J. X. (2005). From fat to fat-1: a tale of omega-3 fatty acids. Journal of Membrane Biology, 206(2), 165-172.
15. Burdge, G. C., & Calder, P. C. (2005). Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reproduction, Nutrition, Development, 45(5), 581-597.
16. Hoagland, K. M., Maier, K. G., Moreno, C., Yu, M., & Roman, R. J. (2001). Cytochrome P450 metabolites of arachidonic acid: novel regulators of renal function. Nephrology, Dialysis, Transplantation, 16(12), 2283-2285.
17. Smith, W. L. (1989). The eicosanoids and their biochemical mechanisms of action. Biochemical Journal, 259(2), 315-324.
18. Arita, M., Yoshida, M., Hong, S., Tjonahen, E., Glickman, J. N., Petasis, N. A., et al. (2005). Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proceedings of the National Academy of Sciences of the United States of America, 102(21), 7671-7676.
19. Bagga, D., Wang, L., Farias-Eisner, R., Glaspy, J. A., & Reddy, S. T. (2003). Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proceedings of the National Academy of Sciences of the United States of America, 100(4), 1751-1756.
20. Jin, Y., Arita, M., Zhang, Q., Saban, D. R., Chauhan, S. K., Chiang, N., et al. (2009). Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Investigative Ophthalmology and Visual Science, 50(10), 4743-4752.
21. Kamiyama, M., Pozzi, A., Yang, L., DeBusk, L. M., Breyer, R. M., & Lin, P. C. (2006). EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival. Oncogene, 25(53), 7019-7028.
22. Nie, D., Lamberti, M., Zacharek, A., Li, L., Szekeres, K., Tang, K., et al. (2000). Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis. Biochemical and Biophysical Research Communications, 267(1), 245-251.
23. Pai, R., Szabo, I. L., Soreghan, B. A., Atay, S., Kawanaka, H., & Tarnawski, A. S. (2001). PGE(2) stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways. Biochemical and Biophysical Research Communications, 286(5), 923-928.
24. Pola, R., Gaetani, E., Flex, A., Aprahamian, T. R., Bosch-Marce, M., Losordo, D. W., et al. (2004). Comparative analysis of the in vivo angiogenic properties of stable prostacyclin analogs: a possible role for peroxisome proliferator-activated receptors. Journal of Molecular and Cellular Cardiology, 36(3), 363-370.
25. Grimminger, F., Wahn, H., Mayer, K., Kiss, L., Walmrath, D., & Seeger, W. (1997). Impact of arachidonic versus eicosapentaenoic acid on exotonin-induced lung vascular leakage: relation to 4-series versus 5-series leukotriene generation. American Journal of Respiratory and Critical Care Medicine, 155(2), 513-519.
26. Samuelsson, B. (1983). Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science, 220(4597), 568-575.
27. Yuan, Y. M., Fang, S. H., Qian, X. D., Liu, L. Y., Xu, L. H., Shi, W. Z., et al. (2009). Leukotriene D4 stimulates the migration but not proliferation of endothelial cells mediated by the cysteinyl leukotriene cyslt(1) receptor via the extracellular signal-regulated kinase pathway. Journal of Pharmacological Sciences, 109(2), 285-292.
28. Spencer, L., Mann, C., Metcalfe, M., Webb, M. B., Pollard, C., Spencer, D., et al. (2009). The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. European Journal of Cancer, 45(19493674), 2077-2086.
29. Kang, J. X., & Weylandt, K. H. (2008). Modulation of inflammatory cytokines by omega-3 fatty acids. Sub-Cellular Biochemistry, 49(18751910), 133-143.
30. Kang, J. X. (2011). Omega-3: a link between global climate change and human health. Biotechnology Advances, 29(4), 388-390.
31. Simopoulos, A. P. (2002). Omega-3 fatty acids in inflammation and autoimmune diseases. Journal of the American College of Nutrition, 21(6), 495-505.
32. Simopoulos, A. P. (2006). Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomedicine and Pharmacotherapy, 60(9), 502-507.
33. Wang, D., & Dubois, R. N. (2010). Eicosanoids and cancer. Nature Reviews. Cancer, 10(3), 181-193.
34. Gately, S., & Li, W. W. (2004). Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Seminars in Oncology, 31(2 Suppl 7), 2-11.
35. Soslow, R. A., Dannenberg, A. J., Rush, D., Woerner, B. M., Khan, K. N., Masferrer, J., et al. (2000). COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer, 89(12), 2637-2645.
36. Gallo, O., Franchi, A., Magnelli, L., Sardi, I., Vannacci, A., Boddi, V., et al. (2001). Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia, 3(1), 53-61.
37. Greenhough, A., Smartt, H. J., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., et al. (2009). The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis, 30(3), 377-386.
38. Kaidi, A., Qualtrough, D., Williams, A. C., & Paraskeva, C. (2006). Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Research, 66(13), 6683-6691.
39. Kyzas, P. A., Stefanou, D., & Agnantis, N. J. (2005). COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma. Modern Pathology, 18(1), 153-160.
40. Su, J. L., Shih, J. Y., Yen, M. L., Jeng, Y. M., Chang, C. C., Hsieh, C. Y., et al. (2004). Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Research, 64(2), 554-564.
41. Chien, M. H., Ku, C. C., Johansson, G., Chen, M. W., Hsiao, M., Su, J. L., et al. (2009). Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway. Carcinogenesis, 30(12), 2005-2013.
42. Lala, P. K., Al-Mutter, N., & Orucevic, A. (1997). Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H/HEJ mice. International Journal of Cancer, 73(3), 371-380.
43. Yoshida, S., Amano, H., Hayashi, I., Kitasato, H., Kamata, M., Inukai, M., et al. (2003). COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo. Laboratory Investigation, 83(10), 1385-1394.
44. Timoshenko, A. V., Chakraborty, C., Wagner, G. F., & Lala, P. K. (2006). COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. British Journal of Cancer, 94(8), 1154-1163.
45. Honn, K. V., Tang, D. G., Gao, X., Butovich, I. A., Liu, B., Timar, J., et al. (1994). 12-lipoxygenases and 12(S)-HETE: role in cancer metastasis. Cancer and Metastasis Reviews, 13(3-4), 365-396.
46. Nie, D., Hillman, G. G., Geddes, T., Tang, K., Pierson, C., Grignon, D. J., et al. (1998). Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth. Cancer Research, 58(18), 4047-4051.
47. Chatterjee, M., Das, S., Roy, K., & Chatterjee, M. (2011). Overexpression of 5-lipoxygenase and its relation with cell proliferation and angiogenesis in 7,12-dimethylbenz(alpha)anthracene-induced rat mammary carcinogenesis. Molecular Carcinogenesis. doi: 10.1002/mc.21858.
48. Ye, Y. N., Liu, E. S., Shin, V. Y., Wu, W. K., & Cho, C. H. (2004). Contributory role of 5-lipoxygenase and its association with angiogenesis in the promotion of inflammation-associated colonic tumorigenesis by cigarette smoking. Toxicology, 203(1-3), 179-188.
49. Romano, M., & Claria, J. (2003). Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. The FASEB Journal, 17(14), 1986-1995.
50. Webler, A. C., Michaelis, U. R., Popp, R., Barbosa-Sicard, E., Murugan, A., Falck, J. R., et al. (2008). Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis. American Journal of Physiology. Cell Physiology, 295(5), C1292-C1301.
51. Michaelis, U. R., Fisslthaler, B., Barbosa-Sicard, E., Falck, J. R., Fleming, I., & Busse, R. (2005). Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis. Journal of Cell Science, 118(Pt 23), 5489-5498.
52. Wang, Y., Wei, X., Xiao, X., Hui, R., Card, J. W., Carey, M. A., et al. (2005). Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways. Journal of Pharmacology and Experimental Therapeutics, 314(2), 522-532.
53. Hyde, C. A., & Missailidis, S. (2009). Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis. International Immunopharmacology, 9(6), 701-715.
54. James, M. J., Gibson, R. A., & Cleland, L. G. (2000). Dietary polyunsaturated fatty acids and inflammatory mediator production. American Journal of Clinical Nutrition, 71(1 Suppl), 343S-348S.
55. Chen, Z. Y., & Istfan, N. W. (2000). Docosahexaenoic acid is a potent inducer of apoptosis in HT-29 colon cancer cells. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 63(5), 301-308.
56. Larsson, S. C., Kumlin, M., Ingelman-Sundberg, M., & Wolk, A. (2004). Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. American Journal of Clinical Nutrition, 79(6), 935-945.
57. Ambring, A., Johansson, M., Axelsen, M., Gan, L., Strandvik, B., & Friberg, P. (2006). Mediterranean-inspired diet lowers the ratio of serum phospholipid n-6 to n-3 fatty acids, the number of leukocytes and platelets, and vascular endothelial growth factor in healthy subjects. American Journal of Clinical Nutrition, 83(3), 575-581.
58. Spencer, L., Mann, C., Metcalfe, M., Webb, M., Pollard, C., Spencer, D., et al. (2009). The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. European Journal of Cancer, 45(12), 2077-2086.
59. Connor, K. M., SanGiovanni, J. P., Lofqvist, C., Aderman, C. M., Chen, J., Higuchi, A., et al. (2007). Increased dietary intake of omega-3- polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nature Medicine, 13(17589522), 868-873.
60. Kang, J. X., & Weylandt, K. H. (2008). Modulation of inflammatory cytokines by omega-3 fatty acids. Sub-Cellular Biochemistry, 49, 133-143.
61. De Caterina, R., & Massaro, M. (2005). Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes. Journal of Membrane Biology, 206(2), 103-116.
62. Weylandt, K. H., & Kang, J. X. (2005). Rethinking lipid mediators. The Lancet, 366(9486), 618-620.
63. Wan, J. B., Huang, L. L., Rong, R., Tan, R., Wang, J., & Kang, J. X. (2010). Endogenously decreasing tissue n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein E-deficient mice by inhibiting systemic and vascular inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(12), 2487-2494.
64. Schmocker, C., Weylandt, K. H., Kahlke, L., Wang, J., Lobeck, H., Tiegs, G., et al. (2007). Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. Hepatology, 45(4), 864-869.
65. Bilal, S., Haworth, O., Wu, L., Weylandt, K. H., Levy, B. D., & Kang, J. X. (2011). Fat-1 transgenic mice with elevated omega-3 fatty acids are protected from allergic airway responses. Biochimica et Biophysica Acta, 1812(9), 1164-1169.
66. Weylandt, K. H., Nadolny, A., Kahlke, L., Kohnke, T., Schmocker, C., Wang, J., et al. (2008). Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis. Biochimica et Biophysica Acta, 1782(11), 634-641.
67. Jia, Q., Lupton, J. R., Smith, R., Weeks, B. R., Callaway, E., Davidson, L. A., et al. (2008). Reduced colitis-associated colon cancer in fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Research, 68(18483285), 3985-3991.
68. White, P. J., Arita, M., Taguchi, R., Kang, J. X., & Marette, A. (2010). Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice. Diabetes, 59(12), 3066-3073.
69. Wada, S., Yamazaki, T., Kawano, Y., Miura, S., & Ezaki, O. (2008). Fish oil fed prior to ethanol administration prevents acute ethanol-induced fatty liver in mice. Journal of Hepatology, 49(3), 441-450.
70. McCusker, M. M., & Grant-Kels, J. M. (2010). Healing fats of the skin: the structural and immunologic roles of the omega-6 and omega-3 fatty acids. Clinics in Dermatology, 28(4), 440-451.
71. Wright, S. A., O'Prey, F. M., McHenry, M. T., Leahey, W. J., Devine, A. B., Duffy, E. M., et al. (2008). A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Annals of the Rheumatic Diseases, 67(6), 841-848.
72. Wang, D., & Dubois, R. N. (2010). Eicosanoids and cancer. Nature Reviews. Cancer, 10(20168319), 181-193.
73. Jackson, J. R., Seed, M. P., Kircher, C. H., Willoughby, D. A., & Winkler, J. D. (1997). The codependence of angiogenesis and chronic inflammation. The FASEB Journal, 11(6), 457-465.
74. Carmeliet, P., & Jain, R. K. (2000). Angiogenesis in cancer and other diseases. Nature, 407(6801), 249-257.
75. Voronov, E., Shouval, D. S., Krelin, Y., Cagnano, E., Benharroch, D., Iwakura, Y., et al. (2003). IL-1 is required for tumor invasiveness and angiogenesis. Proceedings of the National Academy of Sciences of the United States of America, 100(5), 2645-2650.
76. Firestein, G. S. (1999). Starving the synovium: angiogenesis and inflammation in rheumatoid arthritis. Journal of Clinical Investigation, 103(1), 3-4.
77. Storgard, C. M., Stupack, D. G., Jonczyk, A., Goodman, S. L., Fox, R. I., & Cheresh, D. A. (1999). Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. Journal of Clinical Investigation, 103(1), 47-54.
78. MacLean, C. H., Newberry, S. J., Mojica, W. A., Khanna, P., Issa, A. M., Suttorp, M. J., et al. (2006). Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA: The Journal of the American Medical Association, 295(4), 403-415.
79. Terry, P., Bergkvist, L., Holmberg, L., & Wolk, A. (2001). No association between fat and fatty acids intake and risk of colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention, 10(8), 913-914.
80. Godley, P. A., Campbell, M. K., Gallagher, P., Martinson, F. E., Mohler, J. L., & Sandler, R. S. (1996). Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma. Cancer Epidemiology, Biomarkers & Prevention, 5(11), 889-895.
81. Ramon, J. M., Bou, R., Romea, S., Alkiza, M. E., Jacas, M., Ribes, J., et al. (2000). Dietary fat intake and prostate cancer risk: a case-control study in Spain. Cancer Causes & Control, 11(8), 679-685.
82. Leitzmann, M. F., Stampfer, M. J., Michaud, D. S., Augustsson, K., Colditz, G. C., Willett, W. C., et al. (2004). Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. American Journal of Clinical Nutrition, 80(1), 204-216.
83. Simonsen, N., van't Veer, P., Strain, J. J., Martin-Moreno, J. M., Huttunen, J. K., & Navajas, J. F. (1998). Adipose tissue omega-3 and omega-6 fatty acid content and breast cancer in the EURAMIC study. European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer. American Journal of Epidemiology, 147(4), 342-352.
84. Maillard, V., Bougnoux, P., Ferrari, P., Jourdan, M. L., Pinault, M., Lavillonniere, F., et al. (2002). N-3 and N-6 fatty acids in breast adipose tissue and relative risk of breast cancer in a case-control study in Tours, France. International Journal of Cancer, 98(1), 78-83.
85. Williams, C. D., Whitley, B. M., Hoyo, C., Grant, D. J., Iraggi, J. D., Newman, K. A., et al. (2011). A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer. Nutrition Research, 31(1), 1-8.
86. Kang, J. X. (2007). Fat-1 transgenic mice: a new model for omega-3 research. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 77(5-6), 263-267.
87. Hudert, C. A., Weylandt, K. H., Lu, Y., Wang, J., Hong, S., Dignass, A., et al. (2006). Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proceedings of the National Academy of Sciences of the United States of America, 103(30), 11276-11281.
88. Xia, S., Lu, Y., Wang, J., He, C., Hong, S., Serhan, C. N., et al. (2006). Melanoma growth is reduced in fat-1 transgenic mice: impact of omega-6/omega-3 essential fatty acids. Proceedings of the National Academy of Sciences of the United States of America, 103(33), 12499-12504.
89. Berquin, I. M., Min, Y., Wu, R., Wu, J., Perry, D., Cline, J. M., et al. (2007). Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. Journal of Clinical Investigation, 117(7), 1866-1875.
90. Griffitts, J., Saunders, D., Tesiram, Y. A., Reid, G. E., Salih, A., Liu, S., et al. (2010). Non-mammalian fat-1 gene prevents neoplasia when introduced to a mouse hepatocarcinogenesis model: omega-3 fatty acids prevent liver neoplasia. Biochimica et Biophysica Acta, 1801(10), 1133-1144.
91. Jia, Q., Lupton, J. R., Smith, R., Weeks, B. R., Callaway, E., Davidson, L. A., et al. (2008). Reduced colitis-associated colon cancer in fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Research, 68(10), 3985-3991.
92. Kang, J. X., Wang, J., Wu, L., & Kang, Z. B. (2004). Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature, 427(6974), 504.
93. Lim, K., Han, C., Dai, Y., Shen, M., & Wu, T. (2009). Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2. Molecular Cancer Therapeutics, 8(11), 3046-3055.
94. Lu, Y., Nie, D., Witt, W. T., Chen, Q., Shen, M., Xie, H., et al. (2008). Expression of the fat-1 gene diminishes prostate cancer growth in vivo through enhancing apoptosis and inhibiting GSK-3 beta phosphorylation. Molecular Cancer Therapeutics, 7(10), 3203-3211.
95. Nowak, J., Weylandt, K. H., Habbel, P., Wang, J., Dignass, A., Glickman, J. N., et al. (2007). Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n-3 fatty acids. Carcinogenesis, 28(9), 1991-1995.
96. Weylandt, K. H., Krause, L. F., Gomolka, B., Chiu, C. Y., Bilal, S., Nadolny, A., et al. (2011). Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-alpha. Carcinogenesis, 32(6), 897-903.
97. Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., & Willett, W. C. (1994). Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Annals of Internal Medicine, 121(4), 241-246.
98. Wallace, J. M. (2002). Nutritional and botanical modulation of the inflammatory cascade - eicosanoids, cyclooxygenases, and lipoxygenases - as an adjunct in cancer therapy. Integrative Cancer Therapies, 1(1), 7-37.
99. Gogos, C. A., Ginopoulos, P., Salsa, B., Apostolidou, E., Zoumbos, N. C., & Kalfarentzos, F. (1998). Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer, 82(2), 395-402.
100. Okamoto, Y., Okano, K., Izuishi, K., Usuki, H., Wakabayashi, H., & Suzuki, Y. (2009). Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and omega-3 fatty acids supplemented immunonutrition. World Journal of Surgery, 33(9), 1815-1821.
101. Wigmore, S. J., Barber, M. D., Ross, J. A., Tisdale, M. J., & Fearon, K. C. (2000). Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutrition and Cancer, 36(2), 177-184.